Angiotensin-converting enzyme inhibitors but not angiotensin II AT 1 receptor antagonists affect erythropoiesis in patients with anemia of end-stage renal disease (letter)

Schiffl H; Lang SM

首页> 外文期刊>Nephron >Angiotensin-converting enzyme inhibitors but not angiotensin II AT 1 receptor antagonists affect erythropoiesis in patients with anemia of end-stage renal disease (letter)

【24h】

Angiotensin-converting enzyme inhibitors but not angiotensin II AT 1 receptor antagonists affect erythropoiesis in patients with anemia of end-stage renal disease (letter)

机译：血管紧张素转换酶抑制剂对血管紧张素ⅡAT 1受体拮抗剂的影响不大，但对终末期肾脏疾病贫血患者的红细胞生成有影响

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Nephron》 |1999年第1期|共3页
作者
Schiffl H; Lang SM;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类泌尿科学（泌尿生殖系疾病）;
关键词
Anemia; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Erythropoiesis; 贫血; 血管紧张素Ⅱ; 血管紧张素转换酶抑制药; 红细胞生成; 肾功能衰竭; 慢性;

机译：Anemia;Angiotensin II;Angiotensin-Converting Enzyme Inhibitors;Erythropoiesis;贫血;血管紧张素Ⅱ;血管紧张素转换酶抑制药;红细胞生成;肾功能衰竭;慢性;

相似文献

外文文献
中文文献
专利

1. Angiotensin-converting enzyme inhibitors but not angiotensin II AT 1 receptor antagonists affect erythropoiesis in patients with anemia of end-stage renal disease (letter) [J] . Schiffl H, Lang SM Nephron . 1999,第1期

机译：血管紧张素转换酶抑制剂对血管紧张素ⅡAT 1受体拮抗剂的影响不大，但对终末期肾脏疾病贫血患者的红细胞生成有影响
2. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation. [J] . Heinze G, Mitterbauer C, Regele H, Journal of the American Society of Nephrology: JASN . 2006,第3期

机译：血管紧张素转换酶抑制剂或血管紧张素II 1型受体拮抗剂治疗与肾移植后患者和移植物存活时间延长有关。
3. Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for end-stage renal disease/mortality in type 2 diabetes [J] . CampbellH.M., KhanN., RaischD.W., Diabetes research and clinical practice . 2013,第3期

机译：血管紧张素转换酶抑制剂与血管紧张素受体阻滞剂在2型糖尿病终末期肾脏疾病/死亡中的作用
4. The Use of Angiotensin-Converting Enzyme Inhibitors for the Management of Heart Failure in Horses [C] . Conference of the American College of Veterinary Internal Medicine (ACVIM) . 2017

机译：使用血管紧张素转换酶抑制剂在马中的心力衰竭管理
5. Comparison of monotherapy with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in improving health outcomes among veteran patients with type 2 diabetes. [D] . Campbell, Heather M. 2011

机译：与血管紧张素转换酶抑制剂或血管紧张素受体阻滞剂单一疗法改善2型糖尿病退伍军人患者健康结局的比较。
6. A Single-Center Open-Label Randomized Parallel-Group Study Assessing the Differences Between an Angiotensin II Receptor Antagonist and an Angiotensin-Converting Enzyme Inhibitor in Hypertensive Patients with Congestive Heart Failure: The Research for Efficacy of Angiotensin II Receptor Antagonist in Hypertensive Patients with Congestive Heart Failure Study [O] . Nobuo Totsuka, Nobuhisa Awata, Katsuhito Takahashi, 2003

机译：评估充血性心力衰竭高血压患者血管紧张素II受体拮抗剂与血管紧张素转换酶抑制剂之间差异的单中心开放标签随机平行分组研究：高血压患者血管紧张素II受体拮抗剂的疗效研究充血性心力衰竭患者研究
7. Angiotensin-converting enzyme inhibitors but not angiotensin II AT 1 receptor antagonists affect erythropoiesis in patients with anemia of end-stage renal disease [O] . Schiffl Helmut, Lang Susanne M. 1999

机译：血管紧张素转换酶抑制剂而非血管紧张素II aT 1受体拮抗剂影响终末期肾病贫血患者的红细胞生成
8. Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors (ACEls) and Angiotensin II Receptor Antagonists (ARBs) for Treating Essential Hypertension. Comparative Effectiveness Review, Number 10 [R] . Matchar, D. B., McCrory, D. C., Orlando, L. A., 2007

机译：血管紧张素转换酶抑制剂（aCEls）和血管紧张素II受体拮抗剂（aRBs）治疗原发性高血压的疗效比较。比较效力评估，第10号

Angiotensin-converting enzyme inhibitors but not angiotensin II AT 1 receptor antagonists affect erythropoiesis in patients with anemia of end-stage renal disease (letter)

著录项

相似文献

相关主题

期刊订阅